top of page
MedMira
Dec 14, 20212 min read
MedMira announces significant debt reduction and additional growth capital
Halifax, Nova Scotia, 14 December, 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces a financial package of over $5.23 million...
MedMira
Dec 10, 20211 min read
Say Hello to VYRA CoV2Flu! Your answer to "Flurona"..
We are excited to introduce our latest product: VYRA CoV2Flu Rapid Antigen Test Quality, Speed, Ease-of-Use and Design combined - only...
MedMira
Jun 14, 20212 min read
Performance Update on World Health Organisation SARS-CoV2 Serology Standards
Halifax, Nova Scotia, 14 June, 2021 – MedMira Inc. (MedMira) (TSXV: MIR) announces the World Health Organization (WHO) SARS-CoV-2...
MedMira
Mar 3, 20212 min read
Product and Regulatory Update on MedMira’s COVID-19 Product Family
Halifax, Nova Scotia, 03 March, 2021 – MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its product portfolio and outlines...
MedMira
Jan 29, 20212 min read
Progress Update on MedMira’s COVID-19 Product Family
Halifax, Nova Scotia, 29 January, 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the development of a rapid antibody test...
MedMira
Nov 30, 20202 min read
MedMira Announces Product Update
Halifax, Nova Scotia, 30 December, 2020 – Today, MedMira Inc. (MedMira) (TSXV: MIR), is pleased to announce its validated REVEALCOVID-19™...
bottom of page